Kularatne SA - Search Results

1

Design, synthesis, and biological evaluation of novel thiourea derivatives as small molecule inhibitors for prostate specific membrane antigen.

Sengupta S, Pandit A, Krishnan MA, Sharma R, Kularatne SA, Chelvam V. Sengupta S, et al. Among authors: kularatne sa. Bioorg Chem. 2025 Feb;155:108130. doi: 10.1016/j.bioorg.2025.108130. Epub 2025 Jan 4. Bioorg Chem. 2025. PMID: 39787914

2

Development of tumor-targeted near infrared probes for fluorescence guided surgery.

Kelderhouse LE, Chelvam V, Wayua C, Mahalingam S, Poh S, Kularatne SA, Low PS. Kelderhouse LE, et al. Among authors: kularatne sa. Bioconjug Chem. 2013 Jun 19;24(6):1075-80. doi: 10.1021/bc400131a. Epub 2013 May 21. Bioconjug Chem. 2013. PMID: 23642154

3

A folate receptor-α-specific ligand that targets cancer tissue and not sites of inflammation.

Vaitilingam B, Chelvam V, Kularatne SA, Poh S, Ayala-Lopez W, Low PS. Vaitilingam B, et al. Among authors: kularatne sa. J Nucl Med. 2012 Jul;53(7):1127-34. doi: 10.2967/jnumed.111.099390. Epub 2012 Jun 12. J Nucl Med. 2012. PMID: 22693311 Free article.

4

Synthesis and activity of a folate peptide camptothecin prodrug.

Henne WA, Doorneweerd DD, Hilgenbrink AR, Kularatne SA, Low PS. Henne WA, et al. Among authors: kularatne sa. Bioorg Med Chem Lett. 2006 Oct 15;16(20):5350-5. doi: 10.1016/j.bmcl.2006.07.076. Epub 2006 Aug 9. Bioorg Med Chem Lett. 2006. PMID: 16901694

5

Synthesis and biological analysis of prostate-specific membrane antigen-targeted anticancer prodrugs.

Kularatne SA, Venkatesh C, Santhapuram HK, Wang K, Vaitilingam B, Henne WA, Low PS. Kularatne SA, et al. J Med Chem. 2010 Nov 11;53(21):7767-77. doi: 10.1021/jm100729b. J Med Chem. 2010. PMID: 20936874

6

Design, synthesis, and preclinical evaluation of prostate-specific membrane antigen targeted (99m)Tc-radioimaging agents.

Kularatne SA, Zhou Z, Yang J, Post CB, Low PS. Kularatne SA, et al. Mol Pharm. 2009 May-Jun;6(3):790-800. doi: 10.1021/mp9000712. Mol Pharm. 2009. PMID: 19361232 Free PMC article.

7

Prostate-specific membrane antigen targeted imaging and therapy of prostate cancer using a PSMA inhibitor as a homing ligand.

Kularatne SA, Wang K, Santhapuram HK, Low PS. Kularatne SA, et al. Mol Pharm. 2009 May-Jun;6(3):780-9. doi: 10.1021/mp900069d. Mol Pharm. 2009. PMID: 19361233

8

Evaluation of Novel Prostate-Specific Membrane Antigen-Targeted Near-Infrared Imaging Agent for Fluorescence-Guided Surgery of Prostate Cancer.

Kularatne SA, Thomas M, Myers CH, Gagare P, Kanduluru AK, Crian CJ, Cichocki BN. Kularatne SA, et al. Clin Cancer Res. 2019 Jan 1;25(1):177-187. doi: 10.1158/1078-0432.CCR-18-0803. Epub 2018 Sep 10. Clin Cancer Res. 2019. PMID: 30201762

9

Synthesis and activity of folate conjugated didemnin B for potential treatment of inflammatory diseases.

Henne WA, Kularatne SA, Ayala-López W, Doorneweerd DD, Stinnette TW, Lu Y, Low PS. Henne WA, et al. Among authors: kularatne sa. Bioorg Med Chem Lett. 2012 Jan 1;22(1):709-12. doi: 10.1016/j.bmcl.2011.10.042. Epub 2011 Oct 21. Bioorg Med Chem Lett. 2012. PMID: 22100311

10

Development of a Small Molecule Tubulysin B Conjugate for Treatment of Carbonic Anhydrase IX Receptor Expressing Cancers.

Marks IS, Gardeen SS, Kurdziel SJ, Nicolaou ST, Woods JE, Kularatne SA, Low PS. Marks IS, et al. Among authors: kularatne sa. Mol Pharm. 2018 Jun 4;15(6):2289-2296. doi: 10.1021/acs.molpharmaceut.8b00139. Epub 2018 May 1. Mol Pharm. 2018. PMID: 29715036

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

157 results

Search Page

Filters